Analysts from CGS-CIMB Research and RHB Group Research are mixed on UG Healthcare despite posting a “solid” set of results for its FY2021 ended June.


See: UG Healthcare posts record FY2021 earnings of $118.8 mil; proposes 0.506 cent dividend


CGS-CIMB has kept its “add” call but slashed its target price from $1.20 to 65 cents. Meanwhile, RHB kept its “neutral” rating and target price of 57 cents unchanged.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook